XHKG6639
Market cap200mUSD
Dec 23, Last price
2.77HKD
1D
0.36%
1Q
-9.18%
IPO
-79.78%
Name
Arrail Group Ltd
Chart & Performance
P/E
85.19
P/S
0.84
EPS
0.03
Div Yield, %
0.00%
Shrs. gr., 5y
-3.46%
Rev. gr., 5y
10.08%
Revenues
1.75b
+18.46%
Net income
17m
P
CFO
277m
+110.13%
Profile
Arrail Group Limited operates dental hospitals and clinics in China. It operates through Arrail Dental and Rytime Dental brand names. The company's dental services comprise general dentistry; orthodontics; and implantology. As of March 21, 2022, it operated 51 clinics under the Arrail Dental brand and 54 clinics under the Rytime Dental brand; and seven hospitals under the Rytime Dental brand.. The company was founded in 1999 and is based in Beijing, China.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|
| 2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | |
| Income | ||||||
Revenues | 1,745,782 18.46% | 1,473,741 -9.23% | 1,623,553 7.16% | |||
Cost of revenue | 1,488,466 | 1,683,230 | 1,675,632 | |||
Unusual Expense (Income) | ||||||
NOPBT | 257,316 | (209,489) | (52,079) | |||
NOPBT Margin | 14.74% | |||||
Operating Taxes | 3,669 | 5,439 | 13,511 | |||
Tax Rate | 1.43% | |||||
NOPAT | 253,647 | (214,928) | (65,590) | |||
Net income | 17,162 -107.80% | (219,909) -68.63% | (701,032) 16.95% | |||
Dividends | ||||||
Dividend yield | ||||||
Proceeds from repurchase of equity | (10,904) | (34,542) | 527,283 | |||
BB yield | 0.34% | 0.41% | -45.20% | |||
| Debt | ||||||
Debt current | 509,879 | 342,203 | 279,484 | |||
Long-term debt | 1,239,978 | 782,911 | 1,364,495 | |||
Deferred revenue | 16,323 | 21,597 | ||||
Other long-term liabilities | 32,575 | (27,385) | ||||
Net debt | 644,245 | 91,193 | 331,809 | |||
| Cash flow | ||||||
Cash from operating activities | 276,653 | 131,656 | 224,278 | |||
CAPEX | (69,041) | (108,155) | (115,648) | |||
Cash from investing activities | (175,997) | (342,443) | (203,935) | |||
Cash from financing activities | (106,963) | (280,350) | 380,859 | |||
FCF | 432,167 | (608,724) | (2,924,217) | |||
| Balance | ||||||
Cash | 1,103,077 | 937,530 | 1,263,340 | |||
Long term investments | 2,535 | 96,391 | 48,830 | |||
Excess cash | 1,018,323 | 960,234 | 1,230,992 | |||
Stockholders' equity | (3,397,805) | (2,982,703) | (3,067,233) | |||
Invested Capital | 6,320,379 | 5,618,525 | 5,572,466 | |||
ROIC | 4.25% | |||||
ROCE | 8.80% | |||||
| EV | ||||||
Common stock shares outstanding | 487,615 | 579,113 | 80,555 | |||
Price | 6.51 -55.17% | 14.52 0.28% | 14.48 | |||
Market cap | 3,174,374 -62.25% | 8,408,721 620.89% | 1,166,436 | |||
EV | 3,900,709 | 8,585,118 | 1,544,030 | |||
EBITDA | 516,008 | 49,480 | 192,124 | |||
EV/EBITDA | 7.56 | 173.51 | 8.04 | |||
Interest | 46,569 | 44,289 | 46,471 | |||
Interest/NOPBT | 18.10% | |||||